BioWorld

March 19, 2018

View Archived Issues

When tech and health merge, how will life sciences prevail?

The line between health care and technology is becoming blurred. Read More

Tracking public companies focused on hot therapeutic markets

Biopharmaceutical companies had no difficulty attracting capital in 2017. In fact, they raised $52 billion – an amount that places the year solidly in second place in terms of annual totals generated by the industry. Read More

Word on the street

Read More

Week in Washington

Read More

Regulatory submissions, approvals and other actions: February 2018

Read More

Money raised by biotech: 2018 vs. 2017

Read More

Money raised by biotech: Jan. 1 - March 8, 2018

Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More

Week in review

Read More